Recently, Darwish and collaborators designed and tested in AML cells poly lactide co-glycolide (PLGA) nanoparticles conjugated with anti-CD44 and encapsulating PTL (PLGA-antiCD44-PTL-NPs). Here, PNLIP is linked to acute myeloid leukemia.